These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17961100)

  • 41. Determinants of adherence in a cohort of Belgian HIV patients: a pilot study.
    Degroote S; Vogelaers D; Vermeir P; Mariman A; De Rick A; Van Der Gucht B; Pelgrom J; Van Wanzeele F; Verhofstede C; Vancauwenberghe J; Vandijck D
    Acta Clin Belg; 2014 Apr; 69(2):111-5. PubMed ID: 24724750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.
    Eley B; Nuttall J; Davies MA; Smith L; Cowburn C; Buys H; Hussey G
    S Afr Med J; 2004 Aug; 94(8):643-6. PubMed ID: 15352588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing baseline religious practices and beliefs to predict adherence to highly active antiretroviral therapy among HIV-infected persons.
    Vyas KJ; Limneos J; Qin H; Mathews WC
    AIDS Care; 2014; 26(8):983-7. PubMed ID: 24499276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
    Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
    CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radata - implementation of resistance analysis and expert advice for optimized HAART switches in general practice of HIV-infected individuals via a compiling internet presence.
    Paech V; Lorenzen T; Stoehr A; Plettenberg A
    Eur J Med Res; 2002 Jul; 7(7):323-9. PubMed ID: 12176682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiretroviral medication adherence and persistence with respect to adherence tool usage.
    Ostrop NJ; Gill MJ
    AIDS Patient Care STDS; 2000 Jul; 14(7):351-8. PubMed ID: 10935052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.
    Murri R; Ammassari A; Trotta MP; De Luca A; Melzi S; Minardi C; Zaccarelli M; Rellecati P; Santopadre P; Soscia F; Scasso A; Tozzi V; Ciardi M; Orofino GC; Noto P; Monforte Ad; Antinori A; Wu AW;
    J Gen Intern Med; 2004 Nov; 19(11):1104-10. PubMed ID: 15566439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients.
    Etard JF; Lanièce I; Fall MB; Cilote V; Blazejewski L; Diop K; Desclaux A; Ecochard R; Ndoye I; Delaporte E;
    Trop Med Int Health; 2007 Oct; 12(10):1191-8. PubMed ID: 17956501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique.
    San Lio MM; Carbini R; Germano P; Guidotti G; Mancinelli S; Magid NA; Narciso P; Palombi L; Renzi E; Zimba I; Marazzi MC
    Clin Infect Dis; 2008 May; 46(10):1609-16. PubMed ID: 18419498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pilot study of health beliefs and attitudes concerning measures of antiretroviral adherence among prisoners receiving directly observed antiretroviral therapy.
    White BL; Wohl DA; Hays RD; Golin CE; Liu H; Kiziah CN; Simpson G; Kaplan AH
    AIDS Patient Care STDS; 2006 Jun; 20(6):408-17. PubMed ID: 16789854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response.
    Duong M; Piroth L; Peytavin G; Forte F; Kohli E; Grappin M; Buisson M; Chavanet P; Portier H
    Clin Infect Dis; 2001 Aug; 33(3):386-92. PubMed ID: 11438909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients.
    Maggiolo F; Airoldi M; Kleinloog HD; Callegaro A; Ravasio V; Arici C; Bombana E; Suter F
    HIV Clin Trials; 2007; 8(5):282-92. PubMed ID: 17956829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of the WebAd-Q Questionnaire to monitor adherence to HIV therapy.
    Vale FC; Santa-Helena ET; Santos MA; Carvalho WMDES; Menezes PR; Basso CR; Silva MH; Alves AM; Nemes MIB
    Rev Saude Publica; 2018; 52():62. PubMed ID: 29846437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The mean levels of adherence and factors contributing to non-adherence in patients on highly active antiretroviral therapy.
    Williams M; Clarke T; Williams P; Barton EN
    West Indian Med J; 2007 Jun; 56(3):270-4. PubMed ID: 18072411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy.
    Bangsberg DR; Bronstone A; Hofmann R
    AIDS Care; 2002 Feb; 14(1):3-15. PubMed ID: 11798401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers.
    Martin S; Elliott-DeSorbo DK; Calabrese S; Wolters PL; Roby G; Brennan T; Wood LV
    AIDS Patient Care STDS; 2009 Aug; 23(8):593-601. PubMed ID: 19591601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy.
    Mannheimer SB; Mukherjee R; Hirschhorn LR; Dougherty J; Celano SA; Ciccarone D; Graham KK; Mantell JE; Mundy LM; Eldred L; Botsko M; Finkelstein R
    AIDS Care; 2006 Oct; 18(7):853-61. PubMed ID: 16971298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study of the usefulness of pharmacist consultations for patients on antiretroviral regimens].
    Guerrault MN; Leclerc C; Langevin S; Merian-Brosse L; Brossard D; Welker Y
    Presse Med; 2005 Nov; 34(20 Pt 2):1563-70. PubMed ID: 16314815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between HAART adherence and adipose tissue alterations.
    Ammassari A; Antinori A; Cozzi-Lepri A; Trotta MP; Nasti G; Ridolfo AL; Mazzotta F; Wu AW; d'Arminio Monforte A; Galli M;
    J Acquir Immune Defic Syndr; 2002 Dec; 31 Suppl 3():S140-4. PubMed ID: 12562038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.